文献速递造血干细胞移植与细胞治疗血栓与止血

异基因造血细胞移植与移植物抗宿主病中的肠道菌群

The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease.
PubMed 文献 · Blood · 2016-12-09

本文综述肠道菌群在异基因造血细胞移植(allo-HCT)结局及移植物抗宿主病(GVHD)发生中的作用。HCT过程中肠道细菌多样性丧失常见,与GVHD发生及广谱抗生素治疗相关;肠道多样性丧失及变形菌门和肠球菌属机会致病菌过度生长与治疗相关死亡率升高相关。动物模型研究显示益生元和益生菌策略在GVHD预防或治疗中有一些有希望的结果。

要点

  • HCT过程中肠道细菌多样性丧失常见,与GVHD发生及广谱抗生素治疗相关。
  • 变形菌门和肠球菌属机会致病菌过度生长与allo-HCT后治疗相关死亡率升高相关。
  • 动物模型显示益生元和益生菌策略在GVHD预防或治疗中有一些有希望的结果。

核心结论

  • 肠道菌群特征与HCT结局之间的关联需持续研究以明确因果关系。
  • 针对肠道菌群的新策略适用性需通过关注肠道菌群地理和文化差异的研究来确定。

研究设计与样本

  • 综述,检索范围未报告。

主要发现

  • HCT过程中肠道细菌多样性丧失常见,与GVHD发生及广谱抗生素治疗相关。
  • 肠道多样性丧失及变形菌门和肠球菌属机会致病菌过度生长与allo-HCT后治疗相关死亡率升高相关,包括GVHD、感染和器官衰竭。
  • allo-HCT动物模型的实验研究显示益生元和益生菌策略作为GVHD预防或治疗有一些有希望的结果。

临床怎么用

  • 作者认为持续研究对明确菌群特征与HCT结局关联的因果关系很重要。
  • 作者认为关注肠道菌群地理和文化差异的研究对确定靶向肠道菌群新策略的适用性是必要的。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hematopoietic cell transplantation (HCT) is a critical treatment of patients with high-risk hematopoietic malignancies, hematological deficiencies, and other immune diseases. In allogeneic HCT (allo-HCT), donor-derived T cells recognize host tissues as foreign, causing graft-versus-host disease (GVHD) which is a main contributor to morbidity and mortality. The intestine is one of the organs most severely affected by GVHD and research has recently highlighted the importance of bacteria, particularly the gut microbiota, in HCT outcome and in GVHD development. Loss of intestinal bacterial diversity is common during the course of HCT and is associated with GVHD development and treatment with broad-spectrum antibiotics. Loss of intestinal diversity and outgrowth of opportunistic pathogens belonging to the phylum Proteobacteria and Enterococcus genus have also been linked to increased treatment-related mortality including GVHD, infections, and organ failure after allo-HCT. Experimental studies in allo-HCT animal models have shown some promising results for prebiotic and probiotic strategies as prophylaxis or treatment of GVHD. Continuous research will be important to define the relation of cause and effect for these associations between microbiota features and HCT outcomes. Importantly, studies focused on geographic and cultural differences in intestinal microbiota are necessary to define applicability of new strategies targeting the intestinal microbiota.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Staffas A, Burgos da Silva M, van den Brink MR, et al. The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease. Blood. 2016. PMID: 27940475. doi:10.1182/blood-2016-09-691394

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。